4//SEC Filing
White Marvin L 4
Accession 0000950170-24-025878
CIK 0001671584other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:06 PM ET
Size
10.3 KB
Accession
0000950170-24-025878
Insider Transaction Report
Form 4
White Marvin L
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2024-03-02+12,917→ 57,846 total - Exercise/Conversion
Common Stock
2024-03-03+9,584→ 67,430 total - Exercise/Conversion
Restricted Stock Unit
2024-03-02−12,917→ 25,833 total→ Common Stock (12,917 underlying) - Exercise/Conversion
Restricted Stock Unit
2024-03-03−9,584→ 9,584 total→ Common Stock (9,584 underlying)
Footnotes (3)
- [F1]Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
- [F2]On March 3, 2023, the reporting person was granted 38,750 RSUs, vesting in three approximately equal annual installments beginning on March 2, 2024.
- [F3]On June 7, 2022, the reporting person was granted 28,750 RSUs, vesting in three approximately equal annual installments beginning on March 3, 2023.
Documents
Issuer
Aptevo Therapeutics Inc.
CIK 0001671584
Entity typeother
Related Parties
1- filerCIK 0001493324
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 4:06 PM ET
- Size
- 10.3 KB